文献

J-GLOBAL ID：200902278894007907   整理番号：08A1020248

プロスタグランジンE1の持続遊離は糖尿病マウス後肢虚血で塩基性線維芽細胞成長因子による低下した治療血管新生を増強する

Sustained Release of Prostaglandin E₁ Potentiates the Impaired Therapeutic Angiogenesis by Basic Fibroblast Growth Factor in Diabetic Murine Hindlimb Ischemia

著者 (12件)： HUANG Yuhong (Dep. of Cardiovascular Surgery, Kyoto Univ. Graduate School of Medicine) ,  MARUI Akira (Dep. of Cardiovascular Surgery, Kyoto Univ. Graduate School of Medicine) ,  SAKAGUCHI Hisashi (Dep. of Cardiovascular Surgery, Kyoto Univ. Graduate School of Medicine) ,  ESAKI Jiro (Dep. of Cardiovascular Surgery, Kyoto Univ. Graduate School of Medicine) ,  ARAI Yoshio (Dep. of Cardiovascular Surgery, Kyoto Univ. Graduate School of Medicine) ,  HIROSE Keiichi (Dep. of Cardiovascular Surgery, Kyoto Univ. Graduate School of Medicine) ,  BIR Shyamal Chandra (Dep. of Cardiovascular Surgery, Kyoto Univ. Graduate School of Medicine) ,  HORIUCHI Hisanori (Dep. of Cardiovascular Medicine, Kyoto Univ. Graduate School of Medicine) ,  MARUYAMA Takayuki (Minase Res. Inst., Ono Pharmaceutical Co.) ,  IKEDA Tadashi (Dep. of Cardiovascular Surgery, Kyoto Univ. Graduate School of Medicine) ,  TABATA Yasuhiko (Dep. of Biomaterials, Inst. for Frontier Medical Sciences, Kyoto Univ.) ,  KOMEDA Masashi (Dep. of Cardiovascular Surgery, Kyoto Univ. Graduate School of Medicine)
資料名： Circulation Journal  (Circulation Journal)
巻： 72  号： 10  ページ： 1693-1699 (J-STAGE)  発行年： 2008年 
JST資料番号： F0908A  ISSN： 1346-9843  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： 日本 (JPN)  言語： 英語 (EN)

抄録/ポイント： 背景:塩基性線維芽細胞成長因子(bFGF)は強力なマイトジェ...

シソーラス用語： 糖尿病 ,...
準シソーラス用語： ストレプトゾトシン糖尿病

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=08A1020248&from=J-GLOBAL&jstjournalNo=F0908A") }}

分類 (1件)： 血管作用薬・降圧薬の基礎研究  (GW07040J)

物質索引 (1件)： プロスタグランジンE₁

引用文献 (43件)：

• 1. Iwakura A, Tabata Y, Miyao M, Ozeki M, Tamura N, Ikai A, et al. Novel method to enhance sternal healing after harvesting bilateral internal thoracic arteries with use of basic fibroblast growth factor. Circulation 2000; 102(Suppl): III-307-III-311.
• 2. Sakakibara Y, Nishimura K, Tambara K, Yamamoto M, Lu F, Tabata Y, et al. Prevascularization with gelatin microspheres containing basic fibroblast growth factor enhances the benefits of cardiomyocyte transplantation. J Thorac Cardiovasc Surg 2002; 124: 50-56.
• 3. Sakakibara Y, Tambara K, Sakaguchi G, Lu F, Yamamoto M, Nishimura K, et al. Toward surgical angiogenesis using slow-released basic fibroblast growth factor. Eur J Cardiothorac Surg 2003; 24: 105-111.
• 4. Ueyama K, Bing G, Tabata Y, Ozeki M, Doi K, Nishimura K, et al. Development of biologic coronary artery bypass grafting in a rabbit model: Revival of a classic concept with modern biotechnology. J Thorac Cardiovasc Surg 2004; 127: 1608-1615.
• 5. Marui A, Kanematsu A, Yamahara K, Doi K, Kushibiki T, Yamamoto M, et al. Simultaneous application of basic fibroblast growth factor and hepatocyte growth factor to enhance the blood vessels formation. J Vasc Surg 2005; 41: 82-90.

タイトルに関連する用語 (7件)： プロスタグランジンE1 ,  糖尿病マウス ,  肢虚血 ,  塩基性線維芽細胞成長因子 ,  治療 ,  血管新生 ,  増強